Lisa B VanWagner1,2,3, Hongyan Ning2, Maureen Whitsett1, Josh Levitsky1,3,4, Sarah Uttal3, John T Wilkins2,5, Michael M Abecassis3,4, Daniela P Ladner3,4, Anton I Skaro6, Donald M Lloyd-Jones2,5. 1. Department of Medicine, Division of Gastroenterology & Hepatology, Northwestern University Feinberg School of Medicine, Chicago, IL. 2. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL. 3. Northwestern University Transplant Outcomes Research Collaborative, Northwestern University Feinberg School of Medicine, Chicago, IL. 4. Department of Surgery, Division of Organ Transplantation, Northwestern University Feinberg School of Medicine, Chicago, IL. 5. Department of Medicine, Division of Cardiology, Northwestern University Feinberg School of Medicine, Chicago, IL. 6. Department of Surgery, Division of General Surgery and Multi-Organ Transplant, University of Western Ontario Schulich School of Medicine & Dentistry, London, ON, Canada.
Abstract
Cardiovascular disease (CVD) complications are important causes of morbidity and mortality after orthotopic liver transplantation (OLT). There is currently no preoperative risk-assessment tool that allows physicians to estimate the risk for CVD events following OLT. We sought to develop a point-based prediction model (risk score) for CVD complications after OLT, the Cardiovascular Risk in Orthotopic Liver Transplantation risk score, among a cohort of 1,024 consecutive patients aged 18-75 years who underwent first OLT in a tertiary-care teaching hospital (2002-2011). The main outcome measures were major 1-year CVD complications, defined as death from a CVD cause or hospitalization for a major CVD event (myocardial infarction, revascularization, heart failure, atrial fibrillation, cardiac arrest, pulmonary embolism, and/or stroke). The bootstrap method yielded bias-corrected 95% confidence intervals for the regression coefficients of the final model. Among 1,024 first OLT recipients, major CVD complications occurred in 329 (32.1%). Variables selected for inclusion in the model (using model optimization strategies) included preoperative recipient age, sex, race, employment status, education status, history of hepatocellular carcinoma, diabetes, heart failure, atrial fibrillation, pulmonary or systemic hypertension, and respiratory failure. The discriminative performance of the point-based score (C statistic = 0.78, bias-corrected C statistic = 0.77) was superior to other published risk models for postoperative CVD morbidity and mortality, and it had appropriate calibration (Hosmer-Lemeshow P = 0.33). CONCLUSION: The point-based risk score can identify patients at risk for CVD complications after OLT surgery (available at www.carolt.us); this score may be useful for identification of candidates for further risk stratification or other management strategies to improve CVD outcomes after OLT. (Hepatology 2017;66:1968-1979).
Cardiovascular disease (CVD) complications are important causes of morbidity and mortality after orthotopic liver transplantation (OLT). There is currently no preoperative risk-assessment tool that allows physicians to estimate the risk for CVD events following OLT. We sought to develop a point-based prediction model (risk score) for CVD complications after OLT, the Cardiovascular Risk in Orthotopic Liver Transplantation risk score, among a cohort of 1,024 consecutive patients aged 18-75 years who underwent first OLT in a tertiary-care teaching hospital (2002-2011). The main outcome measures were major 1-year CVD complications, defined as death from a CVD cause or hospitalization for a major CVD event (myocardial infarction, revascularization, heart failure, atrial fibrillation, cardiac arrest, pulmonary embolism, and/or stroke). The bootstrap method yielded bias-corrected 95% confidence intervals for the regression coefficients of the final model. Among 1,024 first OLT recipients, major CVD complications occurred in 329 (32.1%). Variables selected for inclusion in the model (using model optimization strategies) included preoperative recipient age, sex, race, employment status, education status, history of hepatocellular carcinoma, diabetes, heart failure, atrial fibrillation, pulmonary or systemic hypertension, and respiratory failure. The discriminative performance of the point-based score (C statistic = 0.78, bias-corrected C statistic = 0.77) was superior to other published risk models for postoperative CVD morbidity and mortality, and it had appropriate calibration (Hosmer-Lemeshow P = 0.33). CONCLUSION: The point-based risk score can identify patients at risk for CVD complications after OLT surgery (available at www.carolt.us); this score may be useful for identification of candidates for further risk stratification or other management strategies to improve CVD outcomes after OLT. (Hepatology 2017;66:1968-1979).
Authors: Lisa B VanWagner; Brittany Lapin; Anton I Skaro; Donald M Lloyd-Jones; Mary E Rinella Journal: Liver Int Date: 2015-06-03 Impact factor: 5.828
Authors: Aoife N Keeling; James D Flaherty; Amir H Davarpanah; Andrew Ambrosy; Cormac T Farrelly; Matthew E Harinstein; Steven L Flamm; Michael I Abecassis; Anton I Skaro; James C Carr; Mihai Gheorghiade Journal: J Cardiovasc Med (Hagerstown) Date: 2011-07 Impact factor: 2.160
Authors: Anna J Dare; Lindsay D Plank; Anthony R J Phillips; Edward J Gane; Barry Harrison; David Orr; Yannan Jiang; Adam S J R Bartlett Journal: Liver Transpl Date: 2014-03 Impact factor: 5.799
Authors: Lynn A Fussner; Julie K Heimbach; Chun Fan; Ross Dierkhising; Elizabeth Coss; Michael D Leise; Kymberly D Watt Journal: Liver Transpl Date: 2015-07 Impact factor: 5.799
Authors: Anas Safadi; Mohamed Homsi; Waddah Maskoun; Kathleen A Lane; Inder Singh; S G Sawada; Jo Mahenthiran Journal: Circulation Date: 2009-09-14 Impact factor: 29.690
Authors: Allison J Kwong; Deepika Devuni; Connie Wang; Justin Boike; Jennifer Jo; Lisa VanWagner; Marina Serper; Lauren Jones; Rajani Sharma; Elizabeth C Verna; Julia Shor; Margarita N German; Alexander Hristov; Alexander Lee; Erin Spengler; Ayman A Koteish; Gurbir Sehmbey; Anil Seetharam; Nimy John; Yuval Patel; Matthew R Kappus; Thomas Couri; Sonali Paul; Reena J Salgia; Quan Nhu; Catherine T Frenette; Jennifer C Lai; Aparna Goel Journal: Liver Transpl Date: 2020-10-13 Impact factor: 5.799
Authors: Samarth S Patel; Fei-Pi Lin; Viviana A Rodriguez; Chandra Bhati; Binu V John; Taylor Pence; Mohammad B Siddiqui; Adam P Sima; Antonio Abbate; Trevor Reichman; Mohammad S Siddiqui Journal: Liver Int Date: 2019-03-26 Impact factor: 5.828
Authors: Lisa B VanWagner; Samantha Montag; Lihui Zhao; Norrina B Allen; Donald M Lloyd-Jones; Arighno Das; Anton I Skaro; Samuel Hohmann; John J Friedewald; Josh Levitsky Journal: Transplantation Date: 2018-07 Impact factor: 4.939
Authors: Leah B Rethy; Megan E McCabe; Kiarri N Kershaw; Faraz S Ahmad; Tara Lagu; Lindsay R Pool; Sadiya S Khan Journal: J Gen Intern Med Date: 2021-05-07 Impact factor: 6.473